Publikationen, an denen er mitarbeitet Patricia Miranda Azpiazu (21)

2024

  1. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  2. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

2023

  1. Electroactive Materials Surface Charge Impacts Neuron Viability and Maturation in 2D Cultures

    ACS Applied Materials and Interfaces, Vol. 15, Núm. 26, pp. 31206-31213

  2. The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases

    Nature Communications, Vol. 14, Núm. 1

2022

  1. A Novel Dynamic Human In Vitro Model for Studying the Blood-Brain Barrier

    Methods in molecular biology (Clifton, N.J.), Vol. 2492, pp. 157-173

  2. Development of 11C-Labeled ASEM Analogues for the Detection of Neuronal Nicotinic Acetylcholine Receptors (α7-nAChR)

    ACS Chemical Neuroscience, Vol. 13, Núm. 3, pp. 352-362

  3. Regulation of Glial Function by Insulin Peptides

    Physiological Consequences of Brain Insulin Action (CRC Press), pp. 53-62

  4. Synthesis and Preclinical Evaluation of [11C]AZ11895530 for PET Imaging of the Serotonin 1A Receptor

    ACS chemical neuroscience, Vol. 13, Núm. 14, pp. 2078-2083

2021

  1. Correction to: Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation (Pharmacological Reports, (2021), 73, 4, (1079-1095), 10.1007/s43440-021-00253-z)

    Pharmacological Reports

  2. Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity

    European Journal of Medicinal Chemistry, Vol. 209

  3. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

    Translational Psychiatry, Vol. 11, Núm. 1

  4. Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1079-1095

2020

  1. Identification and in vitro characterization of C05-01, a PPB3 derivative with improved affinity for alpha-synuclein

    Brain Research, Vol. 1749

  2. Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand

    Journal of Medicinal Chemistry, Vol. 63, Núm. 15, pp. 8608-8633

2019

  1. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

  2. Synthesis, 3H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2

    Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 62, Núm. 6, pp. 265-279

2018

  1. A novel dynamic multicellular co-culture system for studying individual blood-brain barrier cell types in brain diseases and cytotoxicity testing

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

    Science Signaling, Vol. 9, Núm. 410

  2. Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors’ binding pocket

    European Journal of Medicinal Chemistry, Vol. 123, pp. 48-57

2014

  1. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Neuropharmacology, Vol. 86, pp. 311-318